<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-3243</journal-id>
<journal-title><![CDATA[Vive Revista de Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Vive Rev. Salud]]></abbrev-journal-title>
<issn>2664-3243</issn>
<publisher>
<publisher-name><![CDATA[CET-BOLIVIA]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-32432022000200495</article-id>
<article-id pub-id-type="doi">10.33996/revistavive.v5i14.163</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Perfil Lipídico como factor de riesgo de Preeclampsia en mujeres embarazadas]]></article-title>
<article-title xml:lang="en"><![CDATA[Lipid profile as a risk factor for preeclampsia in pregnant women]]></article-title>
<article-title xml:lang="pt"><![CDATA[Perfil lipídico como fator de risco para pré-eclâmpsia em gestantes]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Toledo Bravo]]></surname>
<given-names><![CDATA[Lidia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Román Collazo]]></surname>
<given-names><![CDATA[Carlos Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Católica de Cuenca  ]]></institution>
<addr-line><![CDATA[Cuenca ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>5</volume>
<numero>14</numero>
<fpage>495</fpage>
<lpage>506</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2664-32432022000200495&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2664-32432022000200495&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2664-32432022000200495&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La preeclampsia es una complicación del embarazo, cuya prevalencia se calcula entre 4 y 7% de los embarazos en el mundo. En Ecuador los trastornos hipertensivos fueron causantes del 20,6% de mortalidad materna (años 2017-2018). De allí la importancia de estudios de su diagnóstico oportuno. Objetivo. Asociar el perfil lipídico como factor de riesgo en el padecimiento de preeclampsia de mujeres embarazadas que acudieron al Hospital Sagrado Corazón de Jesús, durante los años 2020-2021. Materiales y Métodos. El tipo de diseño utilizado para la investigación, en una población de 300 embarazadas, fue no experimental, documental, de cohorte, observacional, correlacional y cuantitativo. En el análisis de diferencias significativas entre variables categóricas se usó la prueba Chi cuadrado. Para calcular la relación el padecimiento de Preeclampsia o no en el embarazo con las variables que conforman el perfil lipídico se usó la técnica U de Mann-Whitney. Resultados. El 35,33% de la población de estudio padece preeclampsia. En las variables analizadas como parte del perfil lipídico, mediante la técnica U de Mann-Whitney, se obtuvo un p-valor inferior a 0,5, como se describe a continuación: para triglicéridos &lt;,001; para colesterol HDL 0,421; para colesterol LDL 0,003; y para Colesterol Total &lt;,001. En análisis comparativos con otros estudios se describen resultados similares, pero no en todos coinciden los promedios de comparación. Conclusiones. Existe diferencia estadísticamente significativa en el perfil lipídico de mujeres con preeclampsia, en comparación con el perfil lipídico de mujeres que no padecen preeclampsia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Preeclampsia is a complication of pregnancy, whose prevalence is estimated between 4 and 7% of pregnancies worldwide. In Ecuador, hypertensive disorders were responsible for 20.6% of maternal mortality (years 2017-2018). Hence the importance of studies of their timely diagnosis. Objective. To associate the lipid profile as a risk factor in the suffering of preeclampsia in pregnant women who attended the Hospital Sagrado Corazón de Jesús, during the years 2020-2021. Materials and Methods. The type of design used for the research, in a population of 300 pregnant women, was non-experimental, documentary, cohort, observational, correlational and quantitative. The Chi-square test was used in the analysis of significant differences between categorical variables. The Mann-Whitney U test was used to calculate the relationship between preeclampsia or not during pregnancy and the variables that make up the lipid profile. Results. Preeclampsia was found in 35.33% of the study population. In the variables analyzed as part of the lipid profile, using the Mann-Whitney U technique, a p-value of less than 0.5 was obtained, as described below: for triglycerides &lt;.001; for HDL cholesterol 0.421; for LDL cholesterol 0.003; and for total cholesterol &lt;.001. In comparative analyses with other studies, similar results are described, but not in all the comparison averages coincide. Conclusions. There is a statistically significant difference in the lipid profile of women with preeclampsia compared to the lipid profile of women without preeclampsia]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO A pré-eclâmpsia é uma complicação da gravidez, cuja prevalência é estimada entre 4 e 7% das gestações em todo o mundo. No Equador, as doenças hipertensivas foram responsáveis por 20,6% da mortalidade materna (2017-2018). Daí a importância dos estudos de seu diagnóstico oportuno. Objetivo. Associar o perfil lipídico como fator de risco para pré-eclâmpsia em gestantes que freqüentaram o Hospital Sagrado Corazón de Jesús, durante os anos de 2020-2021. Materiais e métodos. O tipo de projeto de pesquisa utilizado em uma população de 300 mulheres grávidas foi não-experimental, documentário, coorte, observacional, correlacional e quantitativo. O teste Qui-quadrado foi utilizado para analisar diferenças significativas entre as variáveis categóricas. O teste Mann-Whitney U foi usado para calcular a relação entre a pré-eclâmpsia ou não durante a gravidez e as variáveis que compõem o perfil lipídico. Resultados. A pré-eclâmpsia foi encontrada em 35,33% da população do estudo. Nas variáveis analisadas como parte do perfil lipídico, usando a técnica Mann-Whitney U, foi obtido um valor p inferior a 0,5, como segue: para triglicerídeos &lt;,001; para colesterol HDL 0,421; para colesterol LDL 0,003; e para colesterol total &lt;,001. Resultados semelhantes são descritos em análises comparativas com outros estudos, mas nem todas as médias comparativas estão de acordo. Conclusões. Há uma diferença estatisticamente significativa no perfil lipídico das mulheres com pré-eclâmpsia em comparação com o perfil lipídico das mulheres sem pré-eclâmpsia]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Preeclampsia]]></kwd>
<kwd lng="es"><![CDATA[Embarazo]]></kwd>
<kwd lng="es"><![CDATA[Dislipidemia]]></kwd>
<kwd lng="es"><![CDATA[Colesterol]]></kwd>
<kwd lng="es"><![CDATA[Triglicéridos]]></kwd>
<kwd lng="en"><![CDATA[Preeclampsia]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Dyslipidemia]]></kwd>
<kwd lng="en"><![CDATA[Cholesterol]]></kwd>
<kwd lng="en"><![CDATA[Triglycerides]]></kwd>
<kwd lng="pt"><![CDATA[Pré-eclâmpsia]]></kwd>
<kwd lng="pt"><![CDATA[Gravidez]]></kwd>
<kwd lng="pt"><![CDATA[Dislipidemia]]></kwd>
<kwd lng="pt"><![CDATA[Colesterol]]></kwd>
<kwd lng="pt"><![CDATA[Triglicerídeos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phipps]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Thadhani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Benzing]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Karumanchi]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pre-eclampsia: pathogenesis, novel diagnostics and therapies]]></article-title>
<source><![CDATA[Nat Rev Nephrol]]></source>
<year>2019</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>275-89</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarosh]]></surname>
<given-names><![CDATA[Rana]]></given-names>
</name>
<name>
<surname><![CDATA[Elizabeth]]></surname>
<given-names><![CDATA[Lemoine]]></given-names>
</name>
<name>
<surname><![CDATA[Granger Joey]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Karumanchi]]></surname>
<given-names><![CDATA[S. Ananth]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preeclampsia]]></article-title>
<source><![CDATA[Circulation Research]]></source>
<year>2019</year>
<volume>124</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1094-112</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<collab>The American College of Obstetricians and Gynecologistics</collab>
<article-title xml:lang=""><![CDATA[Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222]]></article-title>
<source><![CDATA[Obstetrics &amp; Gynecology]]></source>
<year>2020</year>
<volume>135</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>237</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jirón]]></surname>
<given-names><![CDATA[MGL]]></given-names>
</name>
<name>
<surname><![CDATA[Meza]]></surname>
<given-names><![CDATA[ISL]]></given-names>
</name>
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[JXD]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[JXD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La Preclampsia, causa de muerte materna y su evolución en Ecuador durante el periodo 2017 - 2018]]></article-title>
<source><![CDATA[RECIAMUC]]></source>
<year>2018</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>149-67</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<collab>Ministerio Salud Pública del Ecuador</collab>
<source><![CDATA[Gaceta de Muerte Materna]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camacho-Méndez]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ventura-Arizmendi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Zárate]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Valencia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilidad de los biomarcadores séricos involucrados en la fisiopatología de la preeclampsia como predictores tempranos de diagnóstico]]></article-title>
<source><![CDATA[Perinatología y Reproducción Humana]]></source>
<year>2018</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-42</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucio]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Villacrés]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Henríquez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sistema de salud de Ecuador]]></article-title>
<source><![CDATA[Salud Pública de México]]></source>
<year>2011</year>
<volume>53</volume>
<page-range>177-87</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alban]]></surname>
<given-names><![CDATA[JJZ]]></given-names>
</name>
<name>
<surname><![CDATA[Navarrete]]></surname>
<given-names><![CDATA[YDM]]></given-names>
</name>
<name>
<surname><![CDATA[Choez]]></surname>
<given-names><![CDATA[BGT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hiperuricemia y perfil lipídico durante el embarazo como predictores de preeclampsia]]></article-title>
<source><![CDATA[Revista Científica Higía de la Salud]]></source>
<year>2021</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>https://revistas.itsup.edu.ec/index.php/Higia/article/view/496</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escobar Zúñiga]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Terán Moreno]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Niveles de colesterol total y triglicéridos en mujeres que padecen preeclampsia comparado con embarazadas sin patología, a término, en el Hospital Gineco-Obstétrico Isidro Ayora y Hospital San Francisco de Quito en el periodo entre enero a marzo 2018]]></article-title>
<source><![CDATA[Repositorio Pontificia Universidad Católica del Ecuador]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedro-Botet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Padial]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Esteban-Salán]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García-Lerín]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pintó]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homogeneización de los valores del perfil lipídico]]></article-title>
<source><![CDATA[Clínica e Investigación en Arteriosclerosis]]></source>
<year>2018</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>36-48</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herring]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Oken]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ganancia de peso durante el embarazo: Su importancia para el estado de salud materno-infantil]]></article-title>
<source><![CDATA[Ann Nestlé]]></source>
<year>2010</year>
<volume>68</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-28</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hutcheon]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Bodnar]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Good Practices for Observational Studies of Maternal Weight and Weight Gain in Pregnancy]]></article-title>
<source><![CDATA[Paediatr Perinat Epidemiol]]></source>
<year>2018</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>152-60</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velásquez]]></surname>
<given-names><![CDATA[ACB]]></given-names>
</name>
<name>
<surname><![CDATA[Niño]]></surname>
<given-names><![CDATA[ILC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metodología de correlación estadística de un sistema integrado de gestión de la calidad en el sector salud]]></article-title>
<source><![CDATA[Signos: Investigación en sistemas de gestión]]></source>
<year>2018</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-39</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cedrón]]></surname>
<given-names><![CDATA[LAA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prueba Chi-Cuadrado en la Estadística No Paramétrica]]></article-title>
<source><![CDATA[Ciencias]]></source>
<year>2017</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<collab>WMA</collab>
<article-title xml:lang=""><![CDATA[The World Medical Association]]></article-title>
<source><![CDATA[Declaración de la AMM sobre las Consideraciones Éticas de las Bases de Datos de Salud y los Biobancos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quijano Anacleto]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<source><![CDATA[Dislipidemia como factor de riesgo de preeclampsia en gestantes atendidas en el Hospital Apoyo I Santiago Apóstol-Utcubamba]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrera-Villalobos]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Leythe]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Beiza]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Alanís]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[PMN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Riesgo de dislipidemia en pacientes que han sufrido preeclampsia]]></article-title>
<source><![CDATA[Arch Inv Mat Inf]]></source>
<year>2010</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>67-70</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mounier-Vehier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Delsart]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertension artérielle de la grossesse : une situation à risque cardiovasculaire]]></article-title>
<source><![CDATA[La Presse Médicale]]></source>
<year>2009</year>
<volume>38</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>600-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hurrell]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Webster]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chappell]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Shennan]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The assessment of blood pressure in pregnant women: pitfalls and novel approaches]]></article-title>
<source><![CDATA[American Journal of Obstetrics and Gynecology]]></source>
<year>2022</year>
<volume>226</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>804-18</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Socha]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Malinowski]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Puk]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Dubiel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wici&#324;ski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia]]></article-title>
<source><![CDATA[Cells]]></source>
<year>2020</year>
<volume>9</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1642</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montaño Estrada]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Fortoul Van der Goes]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
<name>
<surname><![CDATA[Rendón Huerta]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Montaño Estrada]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Fortoul Van der Goes]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
<name>
<surname><![CDATA[Rendón Huerta]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿Qué son los inflamosomas? El NLRP3 como por ejemplo]]></article-title>
<source><![CDATA[Revista de la Facultad de Medicina]]></source>
<year>2017</year>
<volume>60</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-9</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
